Virtual Screening of ACE Inhibitory Tripeptides Containing Tyrosine Residues Based on Molecular Docking

被引:0
|
作者
Sun C. [1 ]
Chen W. [1 ]
Chen Y. [1 ]
Wang S. [1 ]
You Q. [1 ]
机构
[1] College of Life Sciences, Jiangxi Normal University, Nanchang
关键词
ACE inhibitory tripeptide; ACE-C domain; molecular docking; tyrosine;
D O I
10.13386/j.issn1002-0306.2021030111
中图分类号
学科分类号
摘要
In order to obtain ACE inhibitory tripeptides containing tyrosine residues, the online Novopro database was used to construct tripeptides with tyrosine at the C-terminus for virtual screening to obtain tripeptides with selective inhibition of ACE-C domains, and predict their biological activity, water solubility, gastrointestinal absorbability, metabolism, and toxicity and other properties. The four ACE inhibitor peptides with high affinity to angiotensin-converting enzyme (ACE) were calculated by molecular docking, and the in vitro ACE inhibitory activity was determined to explore the relationship between binding sites and effects. The results showed that the four selected tripeptides RWY, FRY, YRY, and RFY had significant ACE inhibitory activity, with IC50 values of 228.67, 113.10, 272.61, and 101.00 μmol/L, respectively. The virtual results of molecular docking showed that RWY, FRY, YRY, and RFY all had high affinity with S1' pocket and produce hydrogen bond interactions. Among them, RFY combined with S1' pocket to produce two hydrogen bonds had the best inhibitory effect. This article used bioinformatics principles to screen tyrosine tripeptides selectively inhibited by the ACE-C domain, providing new possibilities for high-speed screening of ACE inhibitor peptides. © 2021 Editorial Department of Science and Technology of Food Science. All Rights Reserved.
引用
收藏
页码:20 / 27
页数:7
相关论文
共 34 条
  • [1] 45, 10, pp. 241-247, (2020)
  • [2] Yu F, Zhang Z, Luo L, Et al., Identification and molecular docking study of a novel angiotensin-i converting enzyme inhibitory peptide derived from enzymatic hydrolysates of cyclina sinensis[J], Marine Drugs, 16, 11, (2018)
  • [3] Kaiser S, Martin M, Lunow D, Et al., Tryptophan-containing dipeptides are bioavailable and inhibit plasma human angiotensin-converting enzyme in vivo[J], International Dairy Journal, 52, pp. 107-114, (2016)
  • [4] 34, 9, (2013)
  • [5] Bernstein K E, Shen X Z, Gonzalez-Villalobos R A, Et al., Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)[J], Current Opinion in Pharmacology, 11, 2, pp. 105-111, (2011)
  • [6] Regulska K, Stanisz B, Regulski M, Et al., How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor [J], Drug Discovery Today, 19, 11, pp. 1731-1743, (2014)
  • [7] Bernstein K E, Ong F S, Blackwell W B, Et al., A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme[J], Pharmacological Reviews, 65, 1, pp. 1-46, (2013)
  • [8] Wu J, Aluko R E, Nakai S., Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues[J], QSAR & Combinatorial Science, 25, 10, pp. 873-880, (2006)
  • [9] (2018)
  • [10] 29, 1, pp. 16-22, (2020)